Literature DB >> 1687000

Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity.

T Kalland1, G Hedlund, M Dohlsten, P A Lando.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1687000     DOI： 10.1007/978-3-642-50998-8_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  11 in total

1.  Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.

Authors:  H Belfrage; M Dohlsten; G Hedlund; T Kalland
Journal:  Immunology       Date:  1997-02       Impact factor: 7.397

Review 2.  Genetically engineered superantigens in experimental tumor therapy.

Authors:  P Antonsson; J Hansson; T Kalland; P A Lando; L Ohlsson; E Schad; A Svensson; M Dohlsten
Journal:  Springer Semin Immunopathol       Date:  1996

Review 3.  Bacterial pyrogenic exotoxins as superantigens.

Authors:  M Kotb
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

4.  Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy.

Authors:  M Dohlsten; L Abrahmsén; P Björk; P A Lando; G Hedlund; G Forsberg; T Brodin; N R Gascoigne; C Förberg; P Lind
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

5.  T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigens.

Authors:  P A Lando; M Dohlsten; G Hedlund; E Akerblom; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

Review 6.  Monoclonal antibodies and superantigens: a novel therapeutic approach.

Authors:  T Kalland; M Dohlsten; P Lind; A Sundstedt; L Abrahmsén; G Hedlund; P Björk; P A Lando; M Björklund
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

7.  Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo.

Authors:  H Belfrage; M Dohlsten; G Hedlund; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1995-08       Impact factor: 6.968

8.  Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells.

Authors:  G Hedlund; M Dohlsten; C Petersson; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

Review 9.  Targeting of superantigens.

Authors:  T Kalland; M Dohlsten; L Abrahmsén; G Hedlund; P Björk; P A Lando; A Sundstedt; E Akerblom; P Lind
Journal:  Cell Biophys       Date:  1993 Jan-Jun

10.  Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo.

Authors:  M Dohlsten; J Hansson; L Ohlsson; M Litton; T Kalland
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.